Being right about the science is much harder and impressive than being right about the SP. If this drug reaches all the levels of therapeutics we envision then the developers of this drug deserve at least one Nobel Prize. Based on all the possible indications for Leronlimab, I believe NP was being conservative when he predicted a triple digit potential SP for CYDY. Lets keep our fingers crossed. Time will tell if this is irrational exuberance or not. Its not easy, but lets try to be patient and understanding of all involved in this wonderful enterprise.